title: Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab.
authors.forename: P F
authors.initials: PF
authors.lastname: Ferrucci
authors.forename: P A
authors.initials: PA
authors.lastname: Ascierto
authors.forename: J
authors.initials: J
authors.lastname: Pigozzo
authors.forename: M
authors.initials: M
authors.lastname: Del Vecchio
authors.forename: M
authors.initials: M
authors.lastname: Maio
authors.forename: G C
authors.initials: GC
authors.lastname: Antonini Cappellini
authors.forename: M
authors.initials: M
authors.lastname: Guidoboni
authors.forename: P
authors.initials: P
authors.lastname: Queirolo
authors.forename: P
authors.initials: P
authors.lastname: Savoia
authors.forename: M
authors.initials: M
authors.lastname: Mandalà
authors.forename: E
authors.initials: E
authors.lastname: Simeone
authors.forename: S
authors.initials: S
authors.lastname: Valpione
authors.forename: M
authors.initials: M
authors.lastname: Altomonte
authors.forename: F
authors.initials: F
authors.lastname: Spagnolo
authors.forename: E
authors.initials: E
authors.lastname: Cocorocchio
authors.forename: S
authors.initials: S
authors.lastname: Gandini
authors.forename: D
authors.initials: D
authors.lastname: Giannarelli
authors.forename: C
authors.initials: C
authors.lastname: Martinoli